Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MEDI-570 |
Synonyms | |
Therapy Description |
MEDI-570 is a human monoclonal antibody against the inducible T-cell co-stimulator (ICOS, CD278), which may lead to the killing of ICOS-expressing tumor cells (Blood (2020) 136 (Supplement 1): 5-6). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MEDI-570 | MEDI570|MEDI 570 | MEDI-570 is a human monoclonal antibody against the inducible T-cell co-stimulator (ICOS, CD278), which may lead to the killing of ICOS-expressing tumor cells (Blood (2020) 136 (Supplement 1): 5-6). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02520791 | Phase I | MEDI-570 | Anti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell Lymphoma | Active, not recruiting | USA | CAN | 0 |